• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Topics » General Psychiatry » Files

General Psychiatry

METHAMPHETAMINE (Desoxyn) Fact Sheet [G]

November 29, 2023

Methamphetamine is highly addictive when used in its crystal form (“crystal meth”), because it causes an immediate and intense high when snorted or smoked. Its use is generally not recommended. Watch the television show “Breaking Bad” if you’re not convinced! From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

ZOLPIDEM (Ambien, Edluar, Intermezzo, Zolpimist) Fact Sheet [G]

November 29, 2023

Ambien is the original Z-drug, having been initially FDA approved in 1992. It is a good hypnotic that can also help with sleep maintenance, particularly in the ER formulation. The lower-dose sublingual version (Intermezzo) has a shorter duration of action and can be taken in the middle of the night—but we recommend using cheaper generic zaleplon instead for middle-of-the-night awakening. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

VORTIOXETINE (Trintellix) Fact Sheet

November 29, 2023

Vortioxetine is a newer “multimodal” antidepressant with diverse effects on neurotransmitters. Recent data suggest that vortioxetine may have pro-cognitive effects and may be less likely to cause sexual side effects than SSRIs. It is reasonable to try the drug in patients who have complained of SSRI-induced sexual dysfunction. A high prevalence of nausea and the high brand-name price tag are negative factors to consider. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

VITAMIN D Fact Sheet [G]

November 29, 2023

Vitamin D supplementation may be beneficial in depression, but reserve its use for those who have low vitamin D levels, and make sure patients take adequate doses, in the range of 1000–5000 IU daily. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

Diarrhea

November 29, 2023

Passing of loose or watery stools, at least three times in a 24-hour period. Often due to infectious etiology (eg, rotovirus, norovirus, adenoviruses, E. coli) but can occur as a side effect to medications. Most cases resolve with routine over-the-counter treatment. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

SELEGILINE TRANSDERMAL (Emsam) Fact Sheet

November 29, 2023

Emsam is an MAOI patch with less likelihood of dietary interactions at 6 mg, and possibly at higher doses too. Probably fewer side effects than other MAOIs, such as weight gain and sexual side effects, and other potential advantages, including better compliance among patients who do not like swallowing pills and less suicide risk (it’s harder to overdose on a patch than with pills). When MAOIs are indicated, this may be the least risky option to try From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

LITHIUM (Eskalith, Lithobid) Fact Sheet [G]

November 29, 2023

Lithium is the gold standard for bipolar disorder. It is more useful for euphoric mania than for mixed and rapid-cycling types of bipolar disorder, but it is effective for depressive episodes and maintenance treatment of bipolar disorder. It is also known for its antisuicide effects in bipolar and unipolar mood disorders. It is likely underprescribed due to side effect concerns—though most patients tolerate lithium quite well. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

DEXTROMETHORPHAN/BUPROPION (Auvelity) Fact Sheet

November 29, 2023

May provide faster onset of response and may be helpful in treatment-resistant patients; however, the evidence is too limited to endorse these preliminary findings. Risk of misuse and very high cost further limit its use. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

RISPERIDONE (Risperdal) Fact Sheet [G]

November 29, 2023

Tried and true, risperidone’s moderate side effect profile has led to its wide use, and many clinicians consider it their antipsychotic of choice for first-episode psychotic disorders. Just be cautious when dosing higher than 4 mg daily, since akathisia and other side effects are more common. Hyperprolactinemia is fairly common, so be vigilant for symptoms such as lowered libido, amenorrhea, gynecomastia, and galactorrhea. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

FLUVOXAMINE (Luvox, Luvox CR) Fact Sheet [G]

November 29, 2023

Fluvoxamine is used less often due to twice-daily dosing, sedation, risk for drug interactions, and fewer data for uses other than OCD, even though it’s likely just as effective as other SSRIs. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

Previous 1 2 … 13 14 15 16 17 18 19 20 21 … 29 30 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2639254965.jpg
    General Psychiatry

    Psychopharm Secrets: Starting Meds

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.